Virtu KCG Holdings’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Virtu KCG Holdings’s Portfolio CELGZ Stock Details CELGZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-19,069	Closed	-$20K	–	4181
2016 Q4	$20K	Buy	+19,069	New	+$21.4K	﹤0.01%	3236
2016 Q1	–	Sell	-13,504	Closed	-$16K	–	4209
2015 Q4	$16K	Buy	+13,504	New	+$18K	﹤0.01%	3333
2015 Q3	–	Sell	-22,340	Closed	-$46K	–	4281
2015 Q2	$46K	Buy	+22,340	New	+$57.2K	﹤0.01%	3084
2014 Q1	–	Sell	-36,442	Closed	-$99K	–	4596
2013 Q4	$99K	Buy	+36,442	New	+$102K	﹤0.01%	3444

Other funds holding CELGZ

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return

UAS

United Asset Strategies Garden City, New York $1.41B AUM 27.73% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MSTVIM

Messner & Smith Theme Value Investment Management San Diego, California $60.3M AUM 16.8% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Virtu KCG Holdings's CELGZ Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q1 2017, closing a stake of 19,069 shares — an estimated $20K sold.

Virtu KCG Holdings first reported a position in CELGZ in Q4 2013 and held it in 4 quarters. The position peaked at $99K in Q4 2013. 22 funds tracked by Wall St. Rank hold CELGZ as of Q1 2017.

Virtu KCG Holdings reported no remaining Celgene Corporation Contingent Value Rights position as of Q1 2017 after selling out during the quarter.
Virtu KCG Holdings sold 19,069 Celgene Corporation Contingent Value Rights shares in Q1 2017, an estimated $20K.
Virtu KCG Holdings first reported a position in Celgene Corporation Contingent Value Rights in Q4 2013 and held it in 4 quarters.
Virtu KCG Holdings's Celgene Corporation Contingent Value Rights position peaked at $99K in Q4 2013.
22 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.